Skip to Main Content

Author Details

Wendy Winckler
2000
50
43
PMIDPaper TitleJournal TitlePublished Year
34669440Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors.Sci Transl Med2021
34045463Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer.Nature Communications2021
30643118Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.Nat Commun2019
30559381Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2019
30275569Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia.Nat Med2018
30327465Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.Nat Commun2018
27159400Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.JAMA Neurol2016
26928769High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines.Nat Biotechnol2016
24509480Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.Nat Genet2014
24677197Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.Hepatology2014
24759409Guidelines for investigating causality of sequence variants in human disease.Nature2014
25024206Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling.Proc Natl Acad Sci U S A2014
23622249Punctuated evolution of prostate cancer genomes.Cell2013
23770567Mutational heterogeneity in cancer and the search for new cancer-associated genes.Nature2013
22980975Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.Cell2012
22544022Absolute quantification of somatic DNA alterations in human cancer.Nat Biotechnol2012
22885922Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes.Nat Genet2012
22539670RNA-SeQC: RNA-seq metrics for quality control and process optimization.Bioinformatics2012
22876189The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits.PLoS Genet2012
22622578Melanoma genome sequencing reveals frequent PREX2 mutations.Nature2012
22460905The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2012
22908275Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.Proc Natl Acad Sci U S A2012
22610119Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.Nat Genet2012
22817889A landscape of driver mutations in melanoma.Cell2012
21798893The mutational landscape of head and neck squamous cell carcinoma.Science2011
22328973Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.Cancer Discov2011
21221095Integrative genomics viewer.Nat Biotechnol2011
21307934The genomic complexity of primary human prostate cancer.Nature2011
21430775Initial genome sequencing and analysis of multiple myeloma.Nature2011
20878384A role for coding functional variants in HNF4A in type 2 diabetes susceptibility.Diabetologia2011
20601955Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.Nat Genet2010
20179022Integrative analysis of the melanoma transcriptome.Genome Res2010
20129251Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.Cancer Cell2010
20164920The landscape of somatic copy-number alteration across human cancers.Nature2010
19176555A flexible rank-based framework for detecting copy number aberrations from array data.2009
19451690Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.J Clin Invest2009
18552176Drug-sensitive FGFR2 mutations in endometrial carcinoma.Proc Natl Acad Sci U S A2008
19010930Genome-wide functional synergy between amplified and mutated genes in human breast cancer.Cancer Res2008
18948947Somatic mutations affect key pathways in lung adenocarcinoma.Nature2008
18245465Modeling genomic diversity and tumor dependency in malignant melanoma.Cancer Res2008
18426588Major copy proportion analysis of tumor samples using SNP arrays.BMC Bioinformatics2008
17982442Characterizing the cancer genome in lung adenocarcinoma.Nature2007
17327436Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes.Diabetes2007
17130512The Krüppel-like factor 11 (KLF11) Q62R polymorphism is not associated with type 2 diabetes in 8,676 people.Diabetes2006
17065359Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity.Diabetes2006
17033837Common variants in HNF-1 alpha and risk of type 2 diabetes.Diabetologia2006
16046299Association of common variation in the HNF1alpha gene region with risk of type 2 diabetes.Diabetes2005
15705809Comparison of fine-scale recombination rates in humans and chimpanzees.Science2005
15734869Association testing of variants in the hepatocyte nuclear factor 4alpha gene with risk of type 2 diabetes in 7,883 people.Diabetes2005
11053690Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice.Neuromuscular Disorders2000
  • 1 - 50 of 50

Recommended Authors

Collaborators

Broad Institute
Co-authored papers 24
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 23
Broad Institute of Harvard and MIT
Co-authored papers 19
The Broad Institute of Harvard and MIT
Co-authored papers 18
Broad Institute of MIT and Harvard
Co-authored papers 18
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 16
Broad Institute of MIT and Harvard
Co-authored papers 15
Co-authored papers 15
Co-authored papers 14
Co-authored papers 14
Co-authored papers 12
The Broad Institute of Harvard and MIT
Co-authored papers 12
Cystic Fibrosis Foundation
Co-authored papers 11
Broad Institute of Harvard and Massachusetts Institute of Technology (MIT)
Co-authored papers 11
Co-authored papers 9
Janssen Research and Development LLC
Co-authored papers 9
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Co-authored papers 7
Co-authored papers 7
The Broad Institute of MIT and Harvard
Co-authored papers 7
Co-authored papers 7
Massachusetts General Hospital
Co-authored papers 7
Broad Institute of MIT and Harvard
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7